Amarin, FDA Finalize Free Speech Settlement
Amarin Pharma and the U.S. Food and Drug Administration on Tuesday finalized in New York federal court a long-awaited settlement of First Amendment litigation over restrictions on off-label promotion, capping a...To view the full article, register now.
Already a subscriber? Click here to view full article